Orally active combretastatin A-4 analogues presented at ACS meeting by Abbott researchers April 17, 2001
SPC-8490, a third-generation SERM active against gynecological tumors, devoid of uterine stimulation April 12, 2001
Cyclotriphosphazene-platinum(II) conjugate selected by Korean researchers as clinical candidate April 12, 2001
Abbott presents new antimitotic sulfonates and prodrugs with improved PK profile at ACS meeting April 12, 2001
RSS